Skip to main content
Top
Published in: Critical Care 5/2006

Open Access 01-10-2006 | Research

Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study

Authors: Michael J O'Dwyer, Felicity Dempsey, Vivion Crowley, Dermot P Kelleher, Ross McManus, Thomas Ryan

Published in: Critical Care | Issue 5/2006

Login to get access

Abstract

Introduction

Asymmetrical dimethyl arginine (ADMA) is an endogenous non-selective inhibitor of nitric oxide synthase that may influence the severity of organ failure and the occurrence of shock secondary to an infectious insult. Levels may be genetically determined by a promoter polymorphism in a regulatory gene encoding dimethylarginine dimethylaminohydrolase II (DDAH II), which functions by metabolising ADMA to citrulline. The aim of this study was to examine the association between ADMA levels and the severity of organ failure and shock in severe sepsis and also to assess the influence of a promoter polymorphism in DDAH II on ADMA levels.

Methods

A prospective observational study was designed, and 47 intensive care unit (ICU) patients with severe sepsis and 10 healthy controls were enrolled. Serum ADMA and IL-6 were assayed on admission to the ICU and seven days later. Allelic variation for a polymorphism at position -449 in the DDAH II gene was assessed in each patient. Clinical and demographic details were also collected.

Results

On day 1 more ADMA was detectable in the ICU group than in the control group (p = 0.005). Levels subsequently increased during the first week in ICU (p = 0.001). ADMA levels were associated with vasopressor requirements on day one (p = 0.001). ADMA levels and Sequential Organ Failure Assessment scores were directly associated on day one (p = 0.0001) and day seven (p = 0.002). The degree of acidaemia and lactaemia was directly correlated with ADMA levels at both time points (p < 0.01). On day seven, IL-6 was directly correlated with ADMA levels (p = 0.006). The variant allele with G at position -449 in the DDAH II gene was associated with increased ADMA concentrations at both time points (p < 0.05).

Conclusion

Severity of organ failure, inflammation and presence of early shock in severe sepsis are associated with increased ADMA levels. ADMA concentrations may be influenced by a polymorphism in the DDAH II gene.
Literature
1.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.CrossRef
2.
go back to reference Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed
4.
go back to reference Cooke JP, Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48: 489-509. 10.1146/annurev.med.48.1.489CrossRefPubMed Cooke JP, Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48: 489-509. 10.1146/annurev.med.48.1.489CrossRefPubMed
5.
go back to reference Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda RJ, van Leeuwen PA: Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003, 22: 23-30. 10.1054/clnu.2002.0613CrossRefPubMed Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda RJ, van Leeuwen PA: Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003, 22: 23-30. 10.1054/clnu.2002.0613CrossRefPubMed
6.
go back to reference Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345: 588-595. 10.1056/NEJMra002709CrossRefPubMed Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345: 588-595. 10.1056/NEJMra002709CrossRefPubMed
7.
go back to reference Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie J, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al.: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32: 21-30. 10.1097/01.CCM.0000105581.01815.C6CrossRefPubMed Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie J, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al.: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32: 21-30. 10.1097/01.CCM.0000105581.01815.C6CrossRefPubMed
8.
go back to reference Nijveldt RJ, Teerlink T, van Leeuwen PA: The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003, 22: 99-104. 10.1054/clnu.2002.0614CrossRefPubMed Nijveldt RJ, Teerlink T, van Leeuwen PA: The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003, 22: 99-104. 10.1054/clnu.2002.0614CrossRefPubMed
9.
go back to reference Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-γ. Annu Rev Immunol 1997, 15: 749-795. 10.1146/annurev.immunol.15.1.749CrossRefPubMed Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-γ. Annu Rev Immunol 1997, 15: 749-795. 10.1146/annurev.immunol.15.1.749CrossRefPubMed
10.
go back to reference Tran CT, Leiper JM, Vallance P: The DDAH/ADMA/NOS pathway. Atheroscler Suppl 2003, 4: 33-40. 10.1016/S1567-5688(03)00032-1CrossRefPubMed Tran CT, Leiper JM, Vallance P: The DDAH/ADMA/NOS pathway. Atheroscler Suppl 2003, 4: 33-40. 10.1016/S1567-5688(03)00032-1CrossRefPubMed
11.
go back to reference Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance P: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999, 106: 987-992. Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance P: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999, 106: 987-992.
12.
go back to reference Ito A, Tsao PS, Adimoolam S, Kimoto M, Tadashi O, Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999, 99: 3029-3095.CrossRef Ito A, Tsao PS, Adimoolam S, Kimoto M, Tadashi O, Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999, 99: 3029-3095.CrossRef
13.
go back to reference Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den Berghe G: Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 2005, 33: 504-510. 10.1097/01.CCM.0000155784.59297.50CrossRefPubMed Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den Berghe G: Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 2005, 33: 504-510. 10.1097/01.CCM.0000155784.59297.50CrossRefPubMed
14.
go back to reference Jones LC, Tran CT, Leiper JM, Hingorani AD, Vallance P: Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells. Biochem Biophys Res Commun 2003, 310: 836-843. 10.1016/j.bbrc.2003.09.097CrossRefPubMed Jones LC, Tran CT, Leiper JM, Hingorani AD, Vallance P: Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells. Biochem Biophys Res Commun 2003, 310: 836-843. 10.1016/j.bbrc.2003.09.097CrossRefPubMed
15.
go back to reference Ryan R, Thorton J, Duggan E, McGovern E, O'Dwyer MJ, Ryan AW, Kelleher D, Mc Manus R, Ryan T: Gene polymorphism and requirement for vasopressor infusion after cardiac surgery. Ann Thorac Surg 2006, 82: 895-901. 10.1016/j.athoracsur.2006.04.029CrossRefPubMed Ryan R, Thorton J, Duggan E, McGovern E, O'Dwyer MJ, Ryan AW, Kelleher D, Mc Manus R, Ryan T: Gene polymorphism and requirement for vasopressor infusion after cardiac surgery. Ann Thorac Surg 2006, 82: 895-901. 10.1016/j.athoracsur.2006.04.029CrossRefPubMed
16.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710.CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710.CrossRefPubMed
17.
go back to reference Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRefPubMed
18.
go back to reference Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, Boger RH: Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004, 42: 1377-1383. 10.1515/CCLM.2004.257CrossRefPubMed Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, Boger RH: Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004, 42: 1377-1383. 10.1515/CCLM.2004.257CrossRefPubMed
19.
go back to reference Vallance P: Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 2001, 358: 2096-2097. 10.1016/S0140-6736(01)07229-4CrossRefPubMed Vallance P: Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 2001, 358: 2096-2097. 10.1016/S0140-6736(01)07229-4CrossRefPubMed
20.
go back to reference Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375: 408-411. 10.1038/375408a0CrossRefPubMed Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375: 408-411. 10.1038/375408a0CrossRefPubMed
22.
go back to reference Wantanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T: Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 2005, 33: 89-97. 10.1097/01.CCM.0000150025.79100.7DCrossRef Wantanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T: Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 2005, 33: 89-97. 10.1097/01.CCM.0000150025.79100.7DCrossRef
Metadata
Title
Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study
Authors
Michael J O'Dwyer
Felicity Dempsey
Vivion Crowley
Dermot P Kelleher
Ross McManus
Thomas Ryan
Publication date
01-10-2006
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2006
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc5053

Other articles of this Issue 5/2006

Critical Care 5/2006 Go to the issue